Literature DB >> 12915325

N-3 polyunsaturated fatty acids and inflammation in the arterial wall.

P Yaqoob1, P C Calder.   

Abstract

Atherosclerosis, leading to cardiovascular disease, is a chronic condition involving a strong inflammatory component. There is evidence that the n-3 polyunsaturated fatty acids (PUFA) present in oily fish and fish oils protect against cardiovascular disease. While these fatty acids have well-recognised effects on plasma triacylglycerol concentrations, it is likely that they exert beneficial effects through other mechanisms in addition. A large body of evidence suggests that the n-3 PUFA have anti-inflammatory properties, some of which may be manifested in the arterial wall, either directly or indirectly, to modulate the progression of atherosclerosis. This review critically evaluates the evidence for the anti-inflammatory effects of the n-3 PUFA in cells and on pathways which have a direct influence on atherogenesis in the arterial wall.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915325

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  9 in total

Review 1.  Furan fatty acids: occurrence, synthesis, and reactions. Are furan fatty acids responsible for the cardioprotective effects of a fish diet?

Authors:  Gerhard Spiteller
Journal:  Lipids       Date:  2005-08       Impact factor: 1.880

2.  Echium oil reduces atherosclerosis in apoB100-only LDLrKO mice.

Authors:  Lolita M Forrest; Elena Boudyguina; Martha D Wilson; John S Parks
Journal:  Atherosclerosis       Date:  2011-10-29       Impact factor: 5.162

3.  Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice.

Authors:  Ganesh V Halade; Md M Rahman; Paul J Williams; Gabriel Fernandes
Journal:  J Nutr Biochem       Date:  2010-07-24       Impact factor: 6.048

Review 4.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

5.  The Benefits of Omega-3 Fats for Stabilizing and Remodeling Atherosclerosis.

Authors:  James J DiNicolantonio; James H O'Keefe
Journal:  Mo Med       Date:  2020 Jan-Feb

6.  Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications.

Authors:  Sridevi Devaraj; Anthony T Cheung; Ishwarlal Jialal; Steven C Griffen; Danh Nguyen; Nicole Glaser; Thomas Aoki
Journal:  Diabetes       Date:  2007-08-08       Impact factor: 9.461

7.  Obesity resistance and deregulation of lipogenesis in Δ6-fatty acid desaturase (FADS2) deficiency.

Authors:  Wilhelm Stoffel; Ina Hammels; Britta Jenke; Erika Binczek; Inga Schmidt-Soltau; Susanne Brodesser; Margarete Odenthal; Mario Thevis
Journal:  EMBO Rep       Date:  2013-12-30       Impact factor: 8.807

8.  Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases.

Authors:  D Ortuño Sahagún; A L Márquez-Aguirre; S Quintero-Fabián; R I López-Roa; A E Rojas-Mayorquín
Journal:  PPAR Res       Date:  2012-11-28       Impact factor: 4.964

Review 9.  Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation.

Authors:  Ana L Guadarrama-López; Roxana Valdés-Ramos; Beatríz E Martínez-Carrillo
Journal:  J Immunol Res       Date:  2014-02-24       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.